Concord Biotech Q4 Results
- BSE: 543960
- NSE: CONCORDBIO
- ISIN: INE338H01029
- Sector: Biotechnology & Drugs
BSE
1,462.00
17.20 (1.19%)
17.20 (1.19%)Volume9.74 K
Updated: Thu 13 Aug, 2026 | 15:29:54
NSE
1,460.0015.30 (1.06%)
15.30 (1.06%)Volume1.10 L
Updated: Thu 13 Aug, 2026 | 15:29:53
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q4 Results Highlights
Quarter ended Mar 26
Note: Comparison is on QoQ basis
Quarterly - Concord Biotech Q4 Results
*All figures in crores except per share values
| Fiscal Period | Mar 26 | Dec 25 | QoQ Comp | Mar 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 227.09 | 200.81 | 13.09% | 198.40 | -10.62% |
| Depreciation/ Amortization | 19.54 | 18.75 | 4.25% | 13.72 | 33.71% |
| Operating Income | 98.99 | 76.96 | 28.63% | 120.57 | -43.70% |
| Net Income | 88.79 | 64.48 | 37.71% | 95.02 | -36.75% |
| Other Operating Expenses Total | 44.20 | 37.83 | 16.83% | 61.88 | 0.00% |
| Net Income Before Taxes | 114.08 | 86.16 | 32.41% | 128.72 | -37.85% |
| Total Revenue | 326.08 | 277.77 | 17.39% | 318.97 | -24.15% |
| Selling/ General/ Admin Expenses Total | 47.77 | 46.78 | 2.12% | 33.96 | 22.60% |
| Diluted Normalized EPS | 8.70 | 6.31 | 37.89% | 9.08 | -35.14% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.